Implantica prepares Module 2 submission of PMA application to FDA for RefluxStopImplantica has announces finalisation of the five-year CE mark study results as part of the upcoming Module 2 submission (of 3 modules)...
RefluxStop results in 90.9% reduction in GERD-HRQL scoreGerman investigators have reported that the RefluxStop implantable device for the management of gastroesophageal reflux disease (GERD)...
First RefluxStop procedures performed in ItalyImplantica has announced that the first RefluxStop procedures to treat acid reflux have been performed in Italy, a key market where more...
Implantica launches RefluxStop in SpainImplantica has announced that the first two RefluxStop procedures to treat acid reflux have been performed at the Hospital Universitario...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour16 hours ago